文献速递帕金森病与运动障碍

早期帕金森病肠道乙酰胆碱酯酶降低:11C-多奈哌齐PET研究

Decreased intestinal acetylcholinesterase in early Parkinson disease: An 11C-donepezil PET study.
PubMed 文献 · Neurology · 2017-01-18

这项横断面研究纳入19例早期帕金森病(PD)患者(病程1.5±0.6年)和16名年龄匹配对照,用11C-多奈哌齐PET测量外周器官乙酰胆碱酯酶密度。PD患者小肠、结肠和肾脏的示踪剂摄取显著降低,而心肌和胰腺无差异,提示早期PD即存在副交感神经去支配。

要点

  • 早期PD患者小肠11C-多奈哌齐摄取降低14%(p=0.018)
  • 结肠摄取降低22%(p<0.001),肾脏降低14%(p=0.028)
  • 心肌和胰腺乙酰胆碱酯酶水平未见差异

核心结论

  • 早期帕金森病患者小肠、结肠和肾脏的11C-多奈哌齐信号显著降低,提示疾病早期即存在副交感神经去支配。

研究设计与样本

  • 横断面研究,纳入19例早期帕金森病患者(病程1.5±0.6年)和16名年龄匹配对照,进行临床评估、嗅觉测试和11C-多奈哌齐PET测量外周器官乙酰胆碱酯酶密度。

主要发现

  • 帕金森病患者小肠11C-多奈哌齐摄取降低14%(p=0.018)。
  • 结肠摄取降低22%(p<0.001),肾脏降低14%(p=0.028)。
  • 心肌或胰腺乙酰胆碱酯酶水平未见差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate systemic levels of acetylcholinesterase in early Parkinson disease (PD) with 11C-donepezil PET, a potential marker of parasympathetic innervation. METHODS: This was a cross-sectional study with 19 patients with early-stage PD (disease duration 1.5 ± 0.6 years) and 16 age-matched controls who had clinical assessments, olfaction tests, and 11C-donepezil PET to measure acetylcholinesterase density in peripheral organs. RESULTS: The patients with PD showed significantly reduced 11C-donepezil uptake in the small intestine (-14%, p = 0.018), colon (-22%, p < 0.001), and kidneys (-14%, p = 0.028). No difference in myocardial or pancreatic acetylcholinesterase levels was seen. CONCLUSION: We found significantly decreased 11C-donepezil signal in the intestine and kidneys of patients with early PD, suggesting that parasympathetic denervation is present early in the disease course.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Fedorova TD, Seidelin LB, Knudsen K, et al. Decreased intestinal acetylcholinesterase in early Parkinson disease: An 11C-donepezil PET study. Neurology. 2017. PMID: 28100726. doi:10.1212/WNL.0000000000003633

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。